Standout Papers

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection 2022 2026 2023 2024151
  1. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection (2022)
    Sorana Segal‐Maurer, Edwin DeJesus et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 67 standout
Sub-graph 1 of 24

Citing Papers

Passage of the HIV capsid cracks the nuclear pore
2025 Standout
mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
2 intermediate papers

Works of Gary Richmond being referenced

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection
2022 Standout
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
2018

Author Peers

Author Last Decade Papers Cites
Gary Richmond 725 702 203 253 26 1.1k
Frank D. Goebel 679 666 196 510 30 1.2k
F. D. Goebel 638 650 289 395 51 1.3k
Jean‐Marie Ragnaud 682 569 270 395 40 1.2k
Chris Tsoukas 754 661 339 221 47 1.1k
Jean-Guy Baril 743 748 242 427 50 1.3k
Michael Wohlfeiler 729 616 274 195 31 1.0k
Gail Skowron 682 684 329 156 45 1.2k
Sulggi A. Lee 768 695 347 297 37 1.4k
F de Wolf 476 752 229 70 19 933
Jean-Louis Sankalé 734 786 292 107 29 1.1k

All Works

Loading papers...

Rankless by CCL
2026